|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||18.34 mL||91.69 mL||183.39 mL|
|0.5 mM||3.67 mL||18.34 mL||36.68 mL|
|1 mM||1.83 mL||9.17 mL||18.34 mL|
|5 mM||0.37 mL||1.83 mL||3.67 mL|
*The above data is based on the productmolecular weight 545.3. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
GSK1120212 (JTP-74057) strongly prevented the activities of MEK1 and MEK2 kinases rather than activities of other 98 kinases.
Kobe0065 inhibits anchorage-dependent and -independent growth, blocks MEK/ERK activity and induces apoptosis in H-rasG12V transformed NIH3T3…
Cobimetinib R-enantiomer is the R-enantiomer of Cobimetinib, which is a potent, highly selective inhibitor of mitogen-activated protein kina…
U0126-EtOH is an inhibitor of both MEK1 and MEK2 with an IC50 of 72 nM and 58 nM respectively.
Refametinib, also known as RDEA119, BAY 86-9766, is an orally bioavailable selective MEK inhibitor with potential antineoplastic activity.